Catalyst Wire Dossier Catalyst Wire Dossier

PT009

· Pearl Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for PT009, covering 2017-05-09 to 2021-02-26. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Safety and Tolerability of PT010, PT009 and PT003 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease [Phase 3]

See pricing